CIN 1 After Colposcopy: What Does a Low-Grade Result Mean?

CIN 1 after colposcopy means a biopsy found mild, low-grade changes in a thin layer of cells on the surface of the cervix. It is not cancer. These changes often go away by themselves, so the usual plan is monitoring with a repeat test rather than treatment.

CIN stands for cervical intraepithelial neoplasia. It describes abnormal-looking cells confined to the surface lining of the cervix. The grade, from 1 to 3, reflects how abnormal the cells look under a microscope and how much of the lining is affected. CIN 1 is the lowest grade.

This guide is for adults who have a CIN 1 biopsy result. It explains common wording and helps you prepare questions. It cannot interpret your own report or replace the plan from your colposcopy clinic.

CIN 1 itself does not usually cause symptoms. Do not wait for your planned repeat test if you notice new symptoms. The NHS advises seeing a GP or local clinician if you have any of the following, or if symptoms change, get worse or do not feel normal for you:

• Vaginal bleeding that is unusual for you, such as bleeding between periods, after sex or after the menopause.
• A change in your vaginal discharge.
• Pain during sex.
• Pain in your lower back, pelvis or lower tummy.

No. The NHS describes CIN as abnormal cell changes that are not cancer. Cleveland Clinic calls CIN 1 a low-grade change that rarely becomes cancer and often goes away on its own.

The NHS also notes that symptoms like those above are very common and are often caused by other conditions. The point of monitoring is to check that the cells settle, and to pick up the uncommon cases that do not, while changes are still easy to manage.

CIN 1 is usually linked to high-risk HPV, which is often found on screening before colposcopy. The US National Cancer Institute says low-grade changes usually go away on their own and do not need treatment.

Guidance reflects this. The NHS says no immediate treatment is needed for CIN 1 and that you may be offered a follow-up cervical screening test or colposcopy. The 2019 ASCCP risk-based guidelines, used widely in the United States, state that observation is preferred to treatment for CIN 1.

Avoiding unnecessary treatment matters because procedures to remove cervical tissue carry their own small risks. NCI notes that, rarely, treatment can weaken the cervix, which may matter in a future pregnancy.

Cleveland Clinic explains that in CIN 1, abnormal cells affect about one-third of the thickness of the cervical lining. In CIN 2 they affect about one-third to two-thirds, and in CIN 3 more than two-thirds.

The plan changes with the grade. The NHS says no immediate treatment is needed for CIN 1. With CIN 2, you may be offered either a follow-up colposcopy or treatment to remove the cells. With CIN 3, treatment is offered. If your letter mentions more than one grade, or a different term such as CGIN, ask the clinic which finding the plan is based on.

The exact follow-up depends on where you live, your age, your earlier HPV and cell results, and what the colposcopist saw. Some common patterns from published guidance include:

• England: national colposcopy guidance says that people with untreated CIN 1 should have a further screening test in the community at 12 months.
• United States: follow-up is risk-based, using your history and age. NCI lists options such as a repeat HPV test or HPV and Pap co-test at a set interval, or a further colposcopy.
• If CIN 1 keeps being found over time, ASCCP guidance says treatment becomes an acceptable option when it has persisted for 2 years or more. Observation can still be chosen.
• If a later test shows higher-grade changes, the plan is reviewed. Your clinic will explain any new options.

Many people reach colposcopy because high-risk HPV was found on screening. CIN 1 confirms that the virus has caused mild cell changes, but it does not mean the infection is permanent. A later HPV test helps show whether it has cleared.

While you are being monitored, you may be on a shorter recall interval than routine screening. Once follow-up tests are clear, many people return to the normal screening schedule for their age. Confirm with your clinic which interval applies to you, and keep your contact details up to date so recall letters reach you.

Write down the date of your biopsy, the result wording and the date your next test is due. If that date passes without an invitation, contact your GP surgery or colposcopy clinic. A low-grade result is reassuring, but the follow-up test is what confirms the cells have settled.

Bring your colposcopy letter and biopsy report. These questions can help you leave with a clear plan:

• Was CIN 1 the only finding, and did the biopsy and colposcopy agree with my earlier screening result?
• When is my next test, what type of test will it be, and will I be sent an invitation or do I need to book it?
• What result would lead you to suggest treatment or another colposcopy?
• Is there anything about my history, such as a weakened immune system, that changes the usual plan?
• I am pregnant or planning a pregnancy. Does that affect the timing of any follow-up?
• Who do I contact if I develop new bleeding, discharge or pain before my next appointment?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar CIN 1 result were followed up, and what they asked their clinic, can help you write your own list of questions.

Other people's cases are not a diagnosis and cannot predict how your cells will change. We suggest using them only to prepare for the conversation with the team that holds your results.